Equities Research Analysts’ Updated EPS Estimates for July 16th (ANTO, AT, BLK, BTRW, CODI, CRE, CTAS, DFS, DNLM, DRTS)

Equities Research Analysts’ updated eps estimates for Thursday, July 16th:

Antofagasta (LON:ANTO) had its hold rating reiterated by analysts at Berenberg Bank. They currently have a GBX 4,400 price target on the stock.

Ashtead Technology (LON:AT) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a GBX 560 price target on the stock.

Ashtead Technology (LON:AT) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 700 target price on the stock.

BlackRock (NYSE:BLK) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. They currently have $1,364.00 price target on the stock, up from their previous price target of $1,165.00.

Barratt Redrow (LON:BTRW) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 350 price target on the stock.

Barratt Redrow (LON:BTRW) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 348 price target on the stock.

Compass Diversified (NYSE:CODI) had its buy rating reiterated by analysts at TD Cowen. TD Cowen currently has a $12.50 price target on the stock.

Conduit (LON:CRE) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 782 target price on the stock.

Cintas (NASDAQ:CTAS) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. The firm currently has $230.00 target price on the stock, up from their previous target price of $200.00.

Cintas (NASDAQ:CTAS) had its sector perform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $206.00 target price on the stock.

DFS Furniture (LON:DFS) had its buy rating reaffirmed by analysts at Shore Capital Group Ltd. The firm currently has a GBX 200 target price on the stock.

Dunelm Group (LON:DNLM) had its buy rating reissued by analysts at Shore Capital Group Ltd. The firm currently has a GBX 1,000 target price on the stock.

Alpha Tau Medical (NASDAQ:DRTS) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $15.00 price target on the stock.

Ero Copper (NYSE:ERO) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. The firm currently has $34.00 price target on the stock, up from their previous price target of $30.00.

Evotec (NASDAQ:EVO) was downgraded by analysts at Berenberg Bank from a buy rating to a hold rating.

Fresnillo (LON:FRES) was downgraded by analysts at JPMorgan Chase & Co. to an overweight rating. They currently have GBX 4,700 price target on the stock, down from their previous price target of GBX 5,400.

Sensei Biotherapeutics (NASDAQ:FTH) had its buy rating reissued by analysts at BTIG Research. They currently have a $55.00 target price on the stock.

Sensei Biotherapeutics (NASDAQ:FTH) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $55.00 price target on the stock.

Alphabet (NASDAQ:GOOGL) had its outperform rating reiterated by analysts at Wedbush.

Hikma Pharmaceuticals (LON:HIK) had its buy rating reissued by analysts at Citigroup Inc..

Halma (LON:HLMA) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 4,200 price target on the stock.

Harmony Biosciences (NASDAQ:HRMY) had its buy rating reissued by analysts at HC Wainwright. They currently have a $55.00 target price on the stock.

Intermediate Capital Group (LON:ICG) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 2,670 target price on the stock.

Ionis Pharmaceuticals (NASDAQ:IONS) had its peer perform rating reaffirmed by analysts at Wolfe Research.

Kenmare Resources (LON:KMR) had its hold rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 220 price target on the stock.

Leidos (NYSE:LDOS) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

lululemon athletica (NASDAQ:LULU) had its sell rating reiterated by analysts at Truist Financial Corporation. Truist Financial Corporation currently has a $94.00 price target on the stock, down from their previous price target of $115.00.

Marks and Spencer Group (LON:MKS) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

Mueller Industries (NYSE:MLI) was upgraded by analysts at Northcoast Research from a neutral rating to a buy rating. The firm currently has $75.00 price target on the stock.

MS INTERNATIONAL (LON:MSI) had its house stock rating reissued by analysts at Shore Capital Group Ltd.

M.T.I Wireless Edge (LON:MWE) had its house stock rating reaffirmed by analysts at Shore Capital Group Ltd. Shore Capital Group Ltd currently has a GBX 100 price target on the stock.

Pegasystems (NASDAQ:PEGA) had its buy rating reissued by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $58.00 price target on the stock.

Premier Foods (LON:PFD) had its house stock rating reissued by analysts at Shore Capital Group Ltd.

PayPal (NASDAQ:PYPL) was upgraded by analysts at Barclays PLC from an underweight rating to an equal weight rating. Barclays PLC currently has $55.00 target price on the stock.

Rapport Therapeutics (NASDAQ:RAPP) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $65.00 target price on the stock.

SK Telecom (NYSE:SKM) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating.

STAAR Surgical (NASDAQ:STAA) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $40.00 target price on the stock.

UnitedHealth Group (NYSE:UNH) was upgraded by analysts at Robert W. Baird from an underperform rating to a neutral rating. The firm currently has $453.00 price target on the stock, up from their previous price target of $287.00.

Uranium Royalty (NASDAQ:UROY) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $4.50 price target on the stock.

W.R. Berkley (NYSE:WRB) had its underperform rating reaffirmed by analysts at Bank of America Corporation. Bank of America Corporation currently has a $68.00 target price on the stock, down from their previous target price of $74.00.